Achieve Life Sciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ACHV Nasdaq 8731 http://achievelifesciences.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Achieve Life Sciences Inc

Achieve Life Sciences Announces Granting of New Hire Inducement Award - Jan 27th, 2023 9:30 pm
Achieve Life Sciences Announces Last Subject Dosed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation - Jan 9th, 2023 1:00 pm
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q3 2022 Earnings Call Transcript - Dec 29th, 2022 11:02 am
Achieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline Formulation - Dec 21st, 2022 1:00 pm
ACHV: 3Q:22 Results: Target Enrollments Reached - Nov 21st, 2022 11:01 am
Achieve Life Sciences Announces Private Placement of $18.9 Million - Nov 15th, 2022 1:00 pm
Achieve Reports Financial Results for Third Quarter 2022 and Provides Corporate Update - Nov 14th, 2022 9:05 pm
Achieve Announces Early Completion of Target Enrollment in Cytisinicline e-Cigarette Cessation Trial - Nov 8th, 2022 1:00 pm
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 14, 2022 - Oct 31st, 2022 12:00 pm
Achieve Announces Completion of Target Enrollment in the Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation - Sep 27th, 2022 12:00 pm
Achieve Life Sciences Announces Participation at Fall Investor Conferences - Sep 7th, 2022 12:00 pm
ACHV: Autumn Enrollment Completion for ORCA-3 - Aug 15th, 2022 10:16 am
Achieve Reports Financial Results for Second Quarter 2022 and Provides Corporate Update - Aug 11th, 2022 8:05 pm
Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 11, 2022 - Jul 28th, 2022 12:00 pm
Achieve Life Sciences Announces Granting of New Hire Inducement Awards - Jul 1st, 2022 8:05 pm
Achieve Life Sciences Announces Initiation of Phase 2 ORCA-V1 Clinical Trial Evaluating Cytisinicline for Nicotine e-cigarette Cessation - Jun 29th, 2022 12:00 pm
Achieve Life Sciences Announces Participation at H.C. Wainwright 1st Annual Mental Health Conference - Jun 21st, 2022 12:00 pm
Achieve Life Sciences Awarded Grant from the National Institutes of Health to Conduct Phase 2 Trial of Cytisinicline in Nicotine e-cigarette Users - Jun 1st, 2022 12:00 pm
Achieve Life Sciences Announces Participation at LD Micro Invitational Conference - May 26th, 2022 12:00 pm
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022 - May 16th, 2022 5:20 pm